Cognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2022 Results

Go back to Cognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2022 Results

Cogentix Medical (CGNT) Misses Q4 EPS by 6c

April 5, 2022 7:08 AM EDT

Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of $0.16, $0.06 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $125 million versus the consensus estimate of $129.55 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

... More